This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Yingda Xu, PhD
Director at Adimab
Speaker

Profile

Yingda received his Ph.D. degree from Michigan State University in Analytical Chemistry
with focus on mass spectrometry. After a brief postdoc training in proteomics, Yingda joined
the protein analytical science department of BMS for analytical assay development and
validation to support BLA filing and post market commitment. Yingda then moved on to the
protein analytics group in Adimab to broaden his horizon in the antibody discovery and
characterization. At Adimab, Yingda is currently leading the Protein Analytical group to
perform antigen characterization, in-process antibody binding screening, and full spectrum
delivery antibody QC, such as thermal stability, binding affinity by Fortebio and MSD,
LCMS, SEC, epitope binning and mapping, etc.